SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech - Quaterly Results

12 Feb 2024 Evaluate
A decent increase of about 29.57% in the sales to Rs. 442.04 millions was observed for the quarter ended December 2023. The sales figure stood at Rs. 341.16 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 27.66  millions from Rs. 37.60 millions ,decline by -26.44%.The company reported a degrowth in operating Profit to 64.15 millions from 64.95 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 442.04 341.16 29.57 1273.78 1007.36 26.45 1378.84 1154.45 19.44
Other Income 8.30 6.29 31.96 17.59 21.16 -16.87 24.62 17.20 43.14
PBIDT 64.15 64.95 -1.23 209.08 194.94 7.25 266.09 252.74 5.28
Interest 6.47 6.82 -5.13 25.10 20.65 21.55 29.23 14.01 108.64
PBDT 57.68 58.13 -0.77 183.98 174.29 5.56 236.86 238.73 -0.78
Depreciation 17.59 16.01 9.87 52.35 47.43 10.37 63.54 57.71 10.10
PBT 40.09 42.12 -4.82 131.63 126.86 3.76 173.32 181.02 -4.25
TAX 12.43 4.52 175.00 29.68 17.29 71.66 23.31 31.97 -27.09
Deferred Tax 2.57 -3.32 -177.41 -4.57 -8.95 -48.94 -13.69 -7.80 75.51
PAT 27.66 37.60 -26.44 101.95 109.57 -6.95 150.01 149.05 0.64
Equity 126.51 126.51 0.00 126.51 126.51 0.00 126.51 122.17 3.55
PBIDTM(%) 14.51 19.04 -23.77 16.41 19.35 -15.18 19.30 21.89 -11.85

Medicamen Biotech Share Price

289.60 -3.40 (-1.16%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×